Edition:
United States

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

8.00USD
15 Dec 2017
Change (% chg)

$-0.07 (-0.87%)
Prev Close
$8.07
Open
$8.07
Day's High
$8.07
Day's Low
$7.95
Volume
77,698
Avg. Vol
56,213
52-wk High
$8.11
52-wk Low
$4.60

Select another date:

Thu, Nov 30 2017

BRIEF-Sinovac Biotech Announces Update On Nasdaq Matters

* SINOVAC BIOTECH- ‍NASDAQ HEARINGS PANEL GRANTED REQUEST TO EXTEND STAY OF SUSPENSION IN TRADING OF CO'S COMMON SHARES PENDING HEARING ON JAN 11, 2018​ Source text for Eikon: Further company coverage:

BRIEF-Sinovac reports Q4 earnings per share $0.08

* Sinovac files 2016 annual report on form 20-F and reports unaudited fourth quarter 2016 financial results

BRIEF-Sinovac Biotech receives delisting determination letter from Nasdaq

* Sinovac Biotech announces receipt of delisting determination letter from Nasdaq Source text for Eikon: Further company coverage:

BRIEF-Sinobioway Consortium provides update on acquiring Sinovac Biotech at $8 per share

* Sinobioway Consortium provides update on acquiring Sinovac Biotech (Nasdaq: SVA) at the purchase price of $8 per share

BRIEF-Sinovac Biotech preliminary phase III data shows Varicella vaccine was 87.1 pct efficacious against Chickenpox ​

* Sinovac reports preliminary top-line results from phase III clinical trial for Varicella vaccine candidate against Chickenpox

BRIEF-Sinovac Biotech announces certain updates relating to delayed filing of annual report on form 20-F

* Sinovac Biotech announces certain updates relating to delayed filing of annual report on form 20-F

BRIEF-Sinobioway consortium provides update on Sinovac Biotech acquisition

* Sinobioway consortium provides update on acquiring Sinovac Biotech at the purchase price of $8 per share

BRIEF-Shandong Sinobioway's consortium makes an offer to take Sinovac Biotech private

* Says its consortium offers to buy Sinovac Biotech Ltd at $8 per share to take it private

BRIEF-Sinovac Biotech enters into agreement for going-private transaction

* Sinovac Biotech Ltd enters into definitive agreement for going-private transaction

Select another date: